Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Walsh

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of the American Academy of Dermatology|October 12, 2017
Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective studyArvin Ighani, Jorge R Georgakopoulos, Neil H Shear, et al.
Journal of the American Academy of Dermatology|October 10, 2017
A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: A Canadian multicenter retrospective studyArvin Ighani, Jorge R Georgakopoulos, Scott Walsh, et al.
International Journal of Dermatology|January 21, 2015
Pemphigus herpetiformis: a case series and review of the literaturePhilip M Laws, Kara Heelan, Faisal Al-Mohammedi, et al.
International Journal of Dermatology|September 22, 2012
Corticosteroid-induced hyperglycemia is increased 10-fold in patients with pemphigusAfsaneh Alavi, Julia Lowe, Scott Walsh, et al.
Journal of Molecular Biology|February 20, 2002
Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sitesCelia Schiffer, Mark Ultsch, Scott Walsh, et al.
Journal of Cutaneous Medicine and Surgery|January 28, 2018
Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective StudyArvin Ighani, Jorge R Georgakopoulos, Linda L Zhou, et al.
International Journal of Dermatology|February 15, 2019
Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patientsAlejandra Jaque, Alexandra Mereniuk, Scott Walsh, et al.
Indian Journal of Dermatology, Venereology and Leprology|September 10, 2014
Use of rituximab in pemphigus patients with chronic viral hepatitis: report of three casesAmrinder J Kanwar, Keshavamurthy Vinay, Kara Heelan, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2015
Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-RituximabKara Heelan, Shazia Hassan, Grace Bannon, et al.
Molecular Therapy Oncolytics|April 11, 2022
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activityNader El-Sayes, Scott Walsh, Alyssa Vito, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|October 12, 2017
Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective studyArvin Ighani, Jorge R Georgakopoulos, Neil H Shear, et al.
Journal of the American Academy of Dermatology|October 10, 2017
A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: A Canadian multicenter retrospective studyArvin Ighani, Jorge R Georgakopoulos, Scott Walsh, et al.
International Journal of Dermatology|January 21, 2015
Pemphigus herpetiformis: a case series and review of the literaturePhilip M Laws, Kara Heelan, Faisal Al-Mohammedi, et al.
International Journal of Dermatology|September 22, 2012
Corticosteroid-induced hyperglycemia is increased 10-fold in patients with pemphigusAfsaneh Alavi, Julia Lowe, Scott Walsh, et al.
Journal of Molecular Biology|February 20, 2002
Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sitesCelia Schiffer, Mark Ultsch, Scott Walsh, et al.
Journal of Cutaneous Medicine and Surgery|January 28, 2018
Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective StudyArvin Ighani, Jorge R Georgakopoulos, Linda L Zhou, et al.
International Journal of Dermatology|February 15, 2019
Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patientsAlejandra Jaque, Alexandra Mereniuk, Scott Walsh, et al.
Indian Journal of Dermatology, Venereology and Leprology|September 10, 2014
Use of rituximab in pemphigus patients with chronic viral hepatitis: report of three casesAmrinder J Kanwar, Keshavamurthy Vinay, Kara Heelan, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2015
Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-RituximabKara Heelan, Shazia Hassan, Grace Bannon, et al.
Molecular Therapy Oncolytics|April 11, 2022
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activityNader El-Sayes, Scott Walsh, Alyssa Vito, et al.
Pageof 6